Jaguar Health, Inc. (JAGX)
0.319
-0.05
(-12.91%)
USD |
NASDAQ |
Sep 10, 16:00
0.3237
0.00 (0.00%)
After-Hours: 20:00
Jaguar Health Debt to Equity Ratio : 2.767 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.767 |
| March 31, 2026 | -2.42 |
| December 31, 2025 | -2.522 |
| September 30, 2025 | 5.669 |
| June 30, 2025 | 3.822 |
| March 31, 2025 | 8.984 |
| December 31, 2024 | 3.739 |
| September 30, 2024 | 2.129 |
| June 30, 2024 | 1.761 |
| March 31, 2024 | 2.310 |
| December 31, 2023 | 7.477 |
| September 30, 2023 | 26.13 |
| June 30, 2023 | 5.617 |
| March 31, 2023 | 4.666 |
| December 31, 2022 | -53.02 |
| September 30, 2022 | 9.021 |
| June 30, 2022 | 11.99 |
| March 31, 2022 | 4.089 |
| December 31, 2021 | 2.529 |
| September 30, 2021 | 1.291 |
| June 30, 2021 | 0.832 |
| March 31, 2021 | 0.8046 |
| December 31, 2020 | 0.9423 |
| September 30, 2020 | 2.033 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.7628 |
| March 31, 2020 | 0.4672 |
| December 31, 2019 | 0.3678 |
| September 30, 2019 | 0.3494 |
| June 30, 2019 | 1.613 |
| March 31, 2019 | 0.8259 |
| December 31, 2018 | 1.118 |
| September 30, 2018 | 0.8408 |
| June 30, 2018 | 0.6698 |
| March 31, 2018 | 0.5073 |
| December 31, 2017 | 0.9504 |
| September 30, 2017 | 0.5085 |
| June 30, 2017 | -0.7476 |
| March 31, 2017 | -0.5616 |
| December 31, 2016 | -1.584 |
| September 30, 2016 | -15.63 |
| June 30, 2016 | 2.748 |
| March 31, 2016 | 1.269 |
| December 31, 2015 | 1.353 |
| September 30, 2015 | 0.7246 |
| June 30, 2015 | 0.0111 |
| March 31, 2015 | -0.843 |
| June 30, 2014 | 0.076 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Reviva Pharmaceuticals Holdings, Inc. | 0.0095 |
| Jupiter Neurosciences, Inc. | -4.852 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.19M |
| Total Liabilities (Quarterly) | 29.27M |
| Shareholders Equity (Quarterly) | 6.615M |
| Current Ratio | 0.6908 |
| Net Debt Paydown Yield | 27.49% |